malondialdehyde has been researched along with Kidney, Polycystic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D | 1 |
Calvet, JP; Magenheimer, BS; Maser, RL; Vassmer, D | 1 |
2 other study(ies) available for malondialdehyde and Kidney, Polycystic
Article | Year |
---|---|
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome | 2003 |
Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease.
Topics: Aldehydes; Animals; Blood; Disease Progression; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Heterozygote; Kidney; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred C57BL; Oxidative Stress; Oxidoreductases; Polycystic Kidney Diseases; Rats; Rats, Inbred Strains; RNA, Messenger; Sex Characteristics | 2002 |